MJO News and Press, MicroSectors Cannabis 2X Leveraged ETNs

It's an appropriate time to take stock of the developments in the cannabis industry. One year in cannabis can feel like several given the many ups and downs that take place in a 12 month span. 2021 delivered a mixed bag of wins and losses. For further details see: 2021 -...

Jon DeCourcey, formerly of Canaccord now with Viridian Capital Advisors, joins us to discuss recent cannabis earnings and why he favors mid-tier multi-state operators (MSOs) over the Big 5. SAFE Banking expectations, how he sees valuations growing. Why retail investors should be e...

GAGE growing with retail and cultivation assets in MI. TerrAscend deal poised to close in early ’22. Reduce rating to hold and price target to $1.91 reflecting TerrAscend deal. Potential for upside in short term on TerrAscend stock gains on legislative news or additiona...

Exchange traded funds can play a valuable role for many cannabis investors. Three years after legalization in Canada, there is now enough data to evaluate cannabis ETF performance. The AdvisorShares Pure Cannabis ETF has been a superior performer in both good and bad markets. ...

Kristen Yoder, host of The CannaBS Detector and a veteran of the industry, gives an unvarnished take on the cannabis industry. Kristen's #1 complaint about the industry. Why she'd rather be short cannabis stocks than long and where she does feel comfortable putting her money. ...

The cannabis ETF universe has expanded to the point that a variety of interesting choices are available. Cannabis ETFs can play a valuable role for investors, offering a list of advantages. CNBS has a number of characteristics that in combination may lead to superior ETF performan...

Timely, edifying episode with industry expert Brady Cobb. Recent cannabis legislation; moving from optics to real reform. SAFE Banking, uplisting and what it all means for cannabis investors. MSOs, ETFs new and old, future valuations, Florida and NY/NJ markets. Selling to Cres...

Q3/21 results were just the second as a vertically integrated operator. Continue to forecast strong growth and margin expansion as operations scale and acquired assets are integrated. Believe could be a takeout candidate as MSOs continue to target Colorado and other mature US cann...

An executive panel discussion that makes sense of cannabis investing today, including the recent Republican led bill, JPMorgan trading restrictions and SAFE banking. All star panel includes Blake Schroeder, CEO of Medical Marijuana, Luis Merchan, CEO of Flora Growth and Becky Postar, ...

Greenlane Holdings and KushCo recently merged to become one of the biggest makers of cannabis accessories. CEO Nick Kovacevich on margins and why the merger made sense. Getting to profitability and the broader sell-off in cannabis. For further details see: Greenlane CEO ...